William A. Raub

921 total citations
22 papers, 736 citations indexed

About

William A. Raub is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, William A. Raub has authored 22 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in William A. Raub's work include Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers) and Colorectal and Anal Carcinomas (3 papers). William A. Raub is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Lung Cancer Research Studies (3 papers) and Colorectal and Anal Carcinomas (3 papers). William A. Raub collaborates with scholars based in United States, Egypt and South Sudan. William A. Raub's co-authors include Mario J. Saldana, K. S. Sridhar, Alfred H. Brandon, Andrew L. Brickman, Mark S. Soloway, Jeffrey A. Fiedler, Kasi S. Sridhar, Richard J. Thurer, Susan G. Hilsenbeck and Luis E. Raez and has published in prestigious journals such as Cancer, CHEST Journal and The Journal of Urology.

In The Last Decade

William A. Raub

21 papers receiving 704 citations

Peers

William A. Raub

PRM

ONCOL

SURGE

PFM

EPIDE

T R Terry United Kingdom

JoAnn Alvarez United States

Ronald Kodama Canada

Peter Conner Sweden

Jong Myon Bae South Korea

Devin Patel United States

G. Schott Germany

Felix Flock Germany

Reith Sarkar United States

Scott K. Swanson United States

T R Terry United Kingdom

William A. Raub

232 ×0.6

PRM

162 ×0.5

ONCOL

246 ×1.3

SURGE

18 ×0.2

PFM

64 ×0.7

EPIDE

Citations per year, relative to William A. Raub William A. Raub (= 1×) peers T R Terry

Countries citing papers authored by William A. Raub

Since Specialization

Citations

This map shows the geographic impact of William A. Raub's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Raub with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Raub more than expected).

Fields of papers citing papers by William A. Raub

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Raub. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Raub. The network helps show where William A. Raub may publish in the future.

Co-authorship network of co-authors of William A. Raub

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Raub. A scholar is included among the top collaborators of William A. Raub based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Raub. William A. Raub is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lu, Jiade J., May Abdel–Wahab, Alfred H. Brandon, et al.. (2002). High-Dose-Rate Remote Afterloading Intracavitary Br achy therapy for the Treatment of Extrahepatic Biliary Duct Carcinoma. The Cancer Journal. 8(1). 74–78. 22 indexed citations

Bathe, Oliver F., David Levi, Humberto Caldera, et al.. (2000). Radical Resection of Periampullary Tumors in the Elderly: Evaluation of Long‐term Results. World Journal of Surgery. 24(3). 353–358. 63 indexed citations

Lee, Yong J., Judith Hurley, Carolyn Mies, et al.. (1998). A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma. Cancer. 82(3). 503–511. 34 indexed citations

Wolfson, Aaron H., Pasquale Benedetto, Walid Mnaymneh, et al.. (1998). Does a Radiation Dose-Response Relation Exist Concerning Survival of Patients Who Have Soft-Tissue Sarcomas of the Extremities?. American Journal of Clinical Oncology. 21(3). 270–274. 15 indexed citations

Wolfson, Aaron H., Kathryn M. Greven, Robert Y. Kim, et al.. (1998). Adenocarcinoma of the Fallopian Tube: Results of a Multi-Institutional Retrospective Analysis of 72 Patients. International Journal of Radiation Oncology*Biology*Physics. 40(1). 71–76. 30 indexed citations

Abitbol, André, Aaron H. Wolfson, Alan A. Lewin, et al.. (1996). Management of Stage I-B, II-A, and II-B Carcinoma of the Cervix with High-Dose-Rate Brachytherapy: Initial Results of an Institutional Clinical Trial. American Journal of Clinical Oncology. 19(3). 223–228. 4 indexed citations

Isobe, Hiroshi, et al.. (1995). Prognostic significance of DNA aneuploidy in diffuse malignant mesothelioma. Cytometry. 19(1). 86–91. 15 indexed citations

Sridhar, K. S., et al.. (1995). Lung Cancer in Patients with Human Immunodeficiency Virus Infection. American Journal of Clinical Oncology. 18(1). 59–66. 23 indexed citations

Feun, Lynn G., Niramol Savaraj, F. Moffat, et al.. (1995). Phase II trial of recombinant interferon-?? with BCNU, cisplatin, DTIC and tamoxifen in advanced malignant melanoma. Melanoma Research. 5(4). 273–276. 11 indexed citations

10.

Brandon, Alfred H., et al.. (1995). Quality of Life: Radical Prostatectomy Versus Radiation Therapy for Prostate Cancer. The Journal of Urology. 154(4). 1420–1425. 184 indexed citations

11.

Brandon, Alfred H., et al.. (1995). Quality of Life. The Journal of Urology. 1420–1425. 4 indexed citations

12.

Broder, Lawrence E., et al.. (1994). A Randomized Clinical Trial in Bronchogenic Small-Cell Carcinoma Evaluating Alternating Maintenance Therapy of Vincristine, Adriamycin, Procarbazine, and Etoposide (VAPE) with Cyclophosphamide, CCNU, and Methotrexate (CCM) versus CCM Maintenance Alone in Complete Responders Following VAPE Induction and Late Intensification. American Journal of Clinical Oncology. 17(6). 527–537. 8 indexed citations

13.

Sridhar, Kasi S., William A. Raub, Norman L. Weatherby, et al.. (1994). Possible Role of Marijuana Smoking as a Carcinogen in the Development of Lung Cancer at a Young Age. Journal of Psychoactive Drugs. 26(3). 285–288. 48 indexed citations

14.

Ghandur‐Mnaymneh, Latifa, William A. Raub, K. S. Sridhar, et al.. (1993). The Accuracy of the Histological Classification of Lung Carcinoma and Its Reproducibility: A Study of 75 Archival Cases of Adenosquamous Carcinoma. Cancer Investigation. 11(6). 641–651. 6 indexed citations

15.

Hilsenbeck, Susan G., William A. Raub, & K. S. Sridhar. (1993). Prognostic Factors in Lung Cancer Based on Multivariate Analysis. American Journal of Clinical Oncology. 16(4). 301–309. 27 indexed citations

16.

Sridhar, Kasi S., et al.. (1992). Lung Cancer in Patients with Human Immunodeficiency Virus Infection Compared with Historic Control Subjects. CHEST Journal. 102(6). 1704–1708. 76 indexed citations

17.

Raub, William A., et al.. (1992). Present and Past Smoking History and Other Predisposing Factors in 100 Lung Cancer Patients. CHEST Journal. 101(1). 19–25. 25 indexed citations

18.

Sridhar, K. S., William A. Raub, Robert Duncan, & Susan G. Hilsenbeck. (1992). The Increasing Recognition of Adenosquamous Lung Carcinoma (1977–1986). American Journal of Clinical Oncology. 15(4). 356–362. 13 indexed citations

19.

Sridhar, K. S., et al.. (1992). New strategies are needed in diffuse malignant mesothelioma. Cancer. 70(12). 2969–2979. 84 indexed citations

20.

Raub, William A., Lynn G. Feun, Robert Duncan, et al.. (1992). Descriptive analysis of the tumor registry experience for malignant melanoma from 1977 to 1986 at the University of Miami School of Medicine/Jackson Memorial Hospital.. PubMed. 16(3). 193–201. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact